3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
155
Observational
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Carcinoma, Non-Small-Cell Lung
13
Melanoma
11
Lung Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Neoplasms
5
Head and Neck Neoplasms
3
Carcinoma, Renal Cell
3
Colorectal Neoplasms
2
Carcinoma, Hepatocellular
2
Biliary Tract Neoplasms
2
Urinary Bladder Neoplasms
1
Uncommon Pathological Types of Lung Cancer
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sexual Dysfunction, Physiological
1
Sarcopenia
1
Prostatic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasms, Squamous Cell
1
Neoplasm Metastasis
1
NSCLC
1
Motor Activity
1
Lung Squamous Cell Carcinoma Stage IV
1
Lung Diseases, Interstitial
1
Liver Diseases
1
Kidney Neoplasms
1
Interventions
Blood Specimen Collection
7
Drug Therapy
6
Surveys and Questionnaires
5
Radiotherapy
5
Radiosurgery
5
Docetaxel
5
Therapeutics
4
Specimen Handling
4
Immunotherapy
4
Hepatectomy
4
exemestane
3
enzalutamide
3
apalutamide
3
Trastuzumab
3
Hematologic Tests
3
Data Collection
3
Biopsy
3
Biological Assay
3
Anastrozole
3
Abiraterone Acetate
3
trastuzumab deruxtecan
2
palbociclib
2
darolutamide
2
abiraterone
2
abemaciclib
2
Wearable Electronic Devices
2
Triptorelin Pamoate
2
Tamoxifen
2
Surgical Procedures, Operative
2
Radiotherapy, Intensity-Modulated
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Neoplasm Metastasis
×
pembrolizumab
×
Clear all
NCT03453892
2023-02-16
ST-ICI
University of Erlangen-Nürnberg Medical School
Completed
150 enrolled